Is at-home ketamine covered by insurance?
Not by any provider in this comparison. Every operating at-home program is self-pay. Some soften that:
- HSA and FSA cards: Mindbloom, Joyous, NutraBrain and Kalm accept them, so you can pay with pre-tax money.
- Superbills: Mindbloom gives you an itemized bill to submit to your insurer yourself. Partial out-of-network reimbursement is possible for the clinician visits, though rarely for the ketamine itself.
- What insurance does cover: Spravato (esketamine), the FDA-approved nasal spray, is often covered for treatment-resistant depression, but only at a certified clinic, never at home. See ketamine vs. Spravato and how insurance covers ketamine treatment.
How at-home programs work
- An online screening and video evaluation with a clinician licensed in your state, who reviews your psychiatric and medical history.
- If approved, a prescription for compounded ketamine — dissolving tablets, troches or lozenges you hold in your mouth, or in some programs a nasal spray or injection — shipped from a compounding pharmacy.
- Doses at home, on a schedule set by the prescriber.
- Follow-up by video, text or app, from weekly check-ins to one or two visits a year depending on the program.
Two very different approaches exist:
- Session-based programs (Mindbloom, Better U) use a dose large enough for a guided experience a few times a month, usually with a sober adult present, blood pressure checked and eyes covered.
- Daily low-dose programs (Joyous, Kalm, Elevate) use small daily doses meant to avoid a strong altered state.
At-home vs. clinic: cost and what you get
At-home programs cost roughly $76–$215 per session or $124–$249 per month for daily low-dose programs (prices published by the providers above). Clinic IV infusions typically run $400–$550 each (median $450); see how much ketamine therapy costs.
The lower price buys less:
- Absorption. Ketamine taken by mouth is absorbed far less efficiently than IV, so effects are gentler, slower and less controllable once taken. Compare IV vs. IM ketamine.
- Monitoring. In a clinic, staff watch your blood pressure and can respond straight away. At home, your safety net is a blood-pressure cuff and whoever is with you.
- Evidence. The strongest trial evidence for ketamine comes from supervised IV dosing. The best-known at-home study — about 1,250 Mindbloom patients, published in 2022 — reported large improvements, but it had no control group and was funded by the company.
Many people use both: an infusion series to get well, then a supervised at-home protocol for maintenance. Find a ketamine clinic near you.
Is at-home ketamine legal?
Yes, for now — with a deadline.
- Federal rule: ketamine is a Schedule III controlled substance. A temporary DEA rule (90 FR 61301) lets clinicians prescribe it by video visit without an in-person exam through December 31, 2026. The DEA has sent a permanent "special registration for telemedicine" rule for White House review. If neither that rule nor another extension takes effect, an in-person visit becomes required again from January 1, 2027. We'll update this page when the rule is published.
- State rules: some states add their own limits on prescribing controlled substances by telehealth, such as requiring an in-person visit first. Check your state's page and ask the provider how they comply.
- FDA status: ketamine is not FDA-approved for depression or any psychiatric condition; at-home ketamine is compounded and prescribed off-label. In 2023 the FDA warned specifically about at-home use of compounded ketamine without on-site monitoring. Compounded ketamine is not "generic Spravato" — they are different drugs.
Safety: who should not do this at home
Responsible programs will screen you out if any of these apply:
- Uncontrolled high blood pressure or significant heart disease — ketamine briefly raises blood pressure and heart rate
- A personal or strong family history of psychosis or mania
- Active substance-use problems — ketamine can be misused, and a home supply makes extra doses easy
- Pregnancy
- No sober adult available during session-based doses
- Combining with sedatives such as benzodiazepines (for example Xanax), opioids or alcohol, which raises the risk of dangerous sedation
Two risks are specific to home use: dose creep, because a supply is on hand, and bladder problems, which are linked to frequent heavy use. A trustworthy program tracks refills and asks about urinary symptoms; one that auto-ships without check-ins is a red flag. The CDC's ketamine fact sheet lists the risks of unmonitored use.
Questions to ask any at-home program
- Is my evaluation a live video visit with a clinician licensed in my state?
- What happens if I have a panic reaction or a medical problem mid-session?
- How are dose changes decided, and what limits refills?
- Is therapy or integration support included, or extra?
- What's the total cost, and what happens if I want to stop?
- What's your plan if the federal telehealth rules change on January 1, 2027?